Yahoo
Shenzhen - Delayed Quote CNY

PKU HealthCare Corp.,Ltd. (000788.SZ)

5.70 -0.16 (-2.73%)
At close: 3:04:18 PM GMT+8
Chart Range Bar
Loading chart for 000788.SZ
  • Previous Close 5.86
  • Open 5.48
  • Bid 5.69 x --
  • Ask 5.70 x --
  • Day's Range 5.56 - 5.91
  • 52 Week Range 4.66 - 7.99
  • Volume 58,912,600
  • Avg. Volume 19,632,054
  • Market Cap (intraday) 3.397B
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) 95.00
  • EPS (TTM) 0.06
  • Earnings Date --
  • Forward Dividend & Yield 0.17 (2.87%)
  • Ex-Dividend Date Mar 10, 2026
  • 1y Target Est --

PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment services related to healthcare management and care delivery, as well as involved in distribution, retail, and hospital sales of pharmaceuticals, medical devices, and consumables. It also provides ceftriaxone sodium, meropenem, and cefminox sodium for injection; moxifloxacin hydrochloride injection; clindamycin palmitate hydrochloride granules; naphazoline capsules; celecoxib capsules; dextroketoneprofen tablets and capsules; buspirone hydrochloride tablets; and olanzapine tablets. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1993 and is headquartered in Chongqing, China.

www.pku-hc.com

789

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/22/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

000788.SZ
4.16%
SSE Composite Index (000001.SS)
7.83%

1-Year Return

000788.SZ
7.49%
SSE Composite Index (000001.SS)
6.53%

3-Year Return

000788.SZ
2.95%
SSE Composite Index (000001.SS)
22.63%

5-Year Return

000788.SZ
6.46%
SSE Composite Index (000001.SS)
2.11%

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    3.22B

  • Enterprise Value

    2.28B

  • Trailing P/E

    84.27

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.32

  • Price/Book (mrq)

    2.12

  • Enterprise Value/Revenue

    2.35

  • Enterprise Value/EBITDA

    22.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.93%

  • Return on Assets (ttm)

    3.16%

  • Return on Equity (ttm)

    2.46%

  • Revenue (ttm)

    972.17M

  • Net Income Avi to Common (ttm)

    38.26M

  • Diluted EPS (ttm)

    0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.03B

  • Total Debt/Equity (mrq)

    5.86%

  • Levered Free Cash Flow (ttm)

    593.67M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: